NCT05920642

Brief Summary

The aim of the study is to investigate postoperative pain relief for patients undergoing surgical treatment of proximal femoral fracture using intrathecal administration of morphine.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 7, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

June 27, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

September 4, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 29, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 29, 2025

Completed
Last Updated

November 25, 2025

Status Verified

November 1, 2025

Enrollment Period

1.9 years

First QC Date

June 7, 2023

Last Update Submit

November 24, 2025

Conditions

Keywords

proximal femur fracturemorphine administrationpain reliefintrathecal administrationparenteral administrationsurgery

Outcome Measures

Primary Outcomes (4)

  • Pain assessment

    Pain intensity will be assessed using the Visual Analogue Scale (VAS10) scale (0-10). The total value of all measured values will be calculated. The maximum value observed during the 24 hours will be also recorded.

    Every 2 hours after the surgery, total of 24 hours

  • Pain assessment during patient positioning

    Pain intensity will be assessed using the VAS10 scale (0-10) during the positioning of the patient.

    24 hours

  • Time to administration of rescue medication

    The time to administration of rescue medication (analgesics) will be observed in hours.

    24 hours

  • Total consumption of opioids on Intensive Care Unit

    The total consumption of opioids on Intensive Care Unit will be measured in the number of administered doses.

    24 hours

Secondary Outcomes (11)

  • Hypoventilation - bradypnea

    24 hours

  • Hypoventilation - presence of hypopnea (TV < 4)

    24 hours

  • Hypoventilation - SpO2

    24 hours

  • Hypoventilation - presence of hypoxemia (paO2) (below 10 kPa)

    24 hours

  • Hypoventilation - other signs of respiratory insufficiency

    24 hours

  • +6 more secondary outcomes

Study Arms (2)

Intrathecal morphine administration

EXPERIMENTAL

Study subjects randomized into this arm will be administered morphine intrathecally in the dose of dose 100 ug.

Drug: Intrathecal morphine administration

Parenteral administration of analgesics

ACTIVE COMPARATOR

Study subjects randomized into this arm will receive standard postoperative pain management (parenteral administration of analgesics).

Drug: Parenteral administration of analgesics

Interventions

Administration of morphine into the spinal canal.

Intrathecal morphine administration

Standard postoperative pain management of analgesics using parenteral route of administration.

Parenteral administration of analgesics

Eligibility Criteria

Age60 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • signed informed consent
  • to 90 years of age
  • surgical treatment of proximal femur fracture
  • The American Society of Anesthesiologists (ASA) classification I to III
  • spinal anesthesia used for the operation

You may not qualify if:

  • general anesthesia used for the operation
  • allergy to opioids
  • high risk of respiratory depression

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Ostrava

Ostrava, Moravian-Silesian Region, 70852, Czechia

Location

Related Publications (3)

  • Rathmell JP, Pino CA, Taylor R, Patrin T, Viani BA. Intrathecal morphine for postoperative analgesia: a randomized, controlled, dose-ranging study after hip and knee arthroplasty. Anesth Analg. 2003 Nov;97(5):1452-1457. doi: 10.1213/01.ANE.0000083374.44039.9E.

    PMID: 14570664BACKGROUND
  • Yamashita K, Fukusaki M, Ando Y, Tanabe T, Terao Y, Sumikawa K. Postoperative analgesia with minidose intrathecal morphine for bipolar hip prosthesis in extremely elderly patients. J Anesth. 2009;23(4):504-7. doi: 10.1007/s00540-009-0817-5. Epub 2009 Nov 18.

    PMID: 19921358BACKGROUND
  • Kwan AS, Lee BB, Brake T. Intrathecal morphine for post-operative analgesia in patients with fractured hips. Hong Kong Med J. 1997 Sep;3(3):250-255.

    PMID: 11847368BACKGROUND

MeSH Terms

Conditions

Proximal Femoral Fractures

Condition Hierarchy (Ancestors)

Femoral Neck FracturesHip FracturesFemoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Study Officials

  • Denis Buršík, MD

    University Hospital Ostrava

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The participant will not know which arm of the study he/she has been enrolled into.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study subjects will be randomized into two parallel groups.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 7, 2023

First Posted

June 27, 2023

Study Start

September 4, 2023

Primary Completion

July 29, 2025

Study Completion

July 29, 2025

Last Updated

November 25, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

There is no plan to make the individual participant data public.

Locations